- Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm
-
Timlin HM, Jiang K, Ezra DG
- KMID: 2511488
- J Mov Disord.
- 2021 Jan;14(1):53-59.
- doi: 10.14802/jmd.20075
Objective To assess the impact of periocular surgery, other than orbicularis stripping, on the severity and frequency of blepharospasm symptoms. Methods Consecutive patients with benign essential blepharospasm (BEB) who underwent eyelid/eyebrow... -
- CITED
-
- Close
- SHARE
-
- Close
- Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers
-
Lubomski M, Davis RL, Sue CM
- KMID: 2511487
- J Mov Disord.
- 2021 Jan;14(1):42-52.
- doi: 10.14802/jmd.20079
Objective Motor and non-motor symptoms (NMS) negatively impact the health-related quality of life (HRQoL) for individuals with Parkinson’s disease (PD), as well as their caregivers. NMS can emerge decades prior... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment
-
Pajo AT, Espiritu AI, Jamora RDG
- KMID: 2511485
- J Mov Disord.
- 2021 Jan;14(1):29-33.
- doi: 10.14802/jmd.20088
-
- CITED
-
- Close
- SHARE
-
- Close
- Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms
-
Mitoma H, Manto M, Hadjivassiliou M
- KMID: 2511484
- J Mov Disord.
- 2021 Jan;14(1):10-28.
- doi: 10.14802/jmd.20040
Since the first description of immune-mediated cerebellar ataxias (IMCAs) by Charcot in 1868, several milestones have been reached in our understanding of this group of neurological disorders. IMCAs have diverse... -
- CITED
-
- Close
- SHARE
-
- Close
- Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
-
Fernando EZ, Yu JRT, Santos SMA, Jamora RDG
- KMID: 2511492
- J Mov Disord.
- 2021 Jan;14(1):75-77.
- doi: 10.14802/jmd.20091
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
-
Poortvliet PC, Gluch A, Silburn PA, Mellick GD
- KMID: 2511486
- J Mov Disord.
- 2021 Jan;14(1):34-41.
- doi: 10.14802/jmd.20034
Objective The consensus is that life expectancy for individuals with Parkinson’s disease (PD) is reduced, but estimations vary. We aimed to provide an overview of 20 years of mortality and... -
- CITED
-
- Close
- SHARE
-
- Close
- Generalized Chorea Due to Secondary Polycythemia Responding to Phlebotomy
-
Cherian A, Paramasivan NK, Puthanveedu DK, Krishnan S, Nair AR
- KMID: 2511497
- J Mov Disord.
- 2021 Jan;14(1):89-91.
- doi: 10.14802/jmd.20081
-
- CITED
-
- Close
- SHARE
-
- Close
- New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia
-
Saathoff Y, Biskup S, Funke C, Roth C
- KMID: 2511491
- J Mov Disord.
- 2021 Jan;14(1):70-74.
- doi: 10.14802/jmd.20082
The genetic testing of hereditary ataxias includes screening for CAG-repeat expansions as well as pathogenic variants and nontranslated oligonucleotide expansion, which can cause spinocerebellar ataxia (SCA). Genotype-phenotype correlations of several... -
- CITED
-
- Close
- SHARE
-
- Close
- Sialidosis Type I without a Cherry Red Spot— Is There a Genetic Basis?
-
Neeraja K, Holla VV, Prasad S, Surisetti BK, Rakesh K, Kamble N, Yadav R, Pal PK
- KMID: 2511490
- J Mov Disord.
- 2021 Jan;14(1):65-69.
- doi: 10.14802/jmd.20083
Sialidosis is an inborn error of metabolism due to a defect in the NEU1 gene and manifests as two phenotypes: mild type I and severe type II. The cherry red... -
- CITED
-
- Close
- SHARE
-
- Close
- The Case of a Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting with a Prolonged History of Stuttering Speech and a Misdiagnosis of Parkinson’s Disease
-
Natteru PA, Huang J
- KMID: 2511496
- J Mov Disord.
- 2021 Jan;14(1):86-88.
- doi: 10.14802/jmd.20062
-
- CITED
-
- Close
- SHARE
-
- Close
- Speech-Induced Task-Specific Cranio-Cervical Tardive Dystonia: An Unusual Phenomenology
-
Holla VV
- KMID: 2511495
- J Mov Disord.
- 2021 Jan;14(1):84-85.
- doi: 10.14802/jmd.20067
-
- CITED
-
- Close
- SHARE
-
- Close
- Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center
-
Prasad S, Bhattacharya A, Sahoo LK, Batra D, Kamble N, Yadav R, Srinivas D, Pal PK
- KMID: 2511489
- J Mov Disord.
- 2021 Jan;14(1):60-64.
- doi: 10.14802/jmd.20066
Objective Willingness to undergo deep brain stimulation (DBS) among patients with Parkinson’s disease (PD) and their overall satisfaction with the procedure is highly dependent upon expectations, which are based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria
-
Tsuboi Y, Mishima T, Fujioka S
- KMID: 2511483
- J Mov Disord.
- 2021 Jan;14(1):1-9.
- doi: 10.14802/jmd.20060
Perry disease is a hereditary neurodegenerative disease with autosomal dominant inheritance. It is characterized by parkinsonism, psychiatric symptoms, unexpected weight loss, central hypoventilation, and transactive-response DNA-binding protein of 43kD (TDP-43)... -
- CITED
-
- Close
- SHARE
-
- Close
- A Rare Case of Green Gelatinous Mass Formation on a Deep Brain Stimulation Implantable Pulse Generator
-
Poortvliet PC, Mellick G, Coyne T, Silburn P
- KMID: 2511494
- J Mov Disord.
- 2021 Jan;14(1):81-83.
- doi: 10.14802/jmd.20050
-
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19: Implications for Sudden Death in Parkinson’s Disease
-
Fiorini AC, Fonseca MCM, Scorza CA, Finsterer J, Rodrigues AM, de Almeida ACG, Scorza FA
- KMID: 2511493
- J Mov Disord.
- 2021 Jan;14(1):78-80.
- doi: 10.14802/jmd.20065
-
- CITED
-
- Close
- SHARE
-
- Close
